Veronica Hill-Milbourne Sells 1,571 Shares of Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Veronica Hill-Milbourne sold 1,571 shares of Addus HomeCare stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total value of $180,555.03. Following the completion of the transaction, the director owned 5,067 shares in the company, valued at $582,350.31. This represents a 23.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Addus HomeCare Trading Up 3.7%

Shares of NASDAQ:ADUS opened at $118.41 on Friday. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72. The business’s fifty day simple moving average is $111.97 and its 200-day simple moving average is $107.10. The company has a market capitalization of $2.18 billion, a PE ratio of 26.14, a P/E/G ratio of 1.74 and a beta of 0.80. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.17.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The business had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. During the same period last year, the business posted $1.35 EPS. The business’s revenue was up 21.8% compared to the same quarter last year. As a group, equities research analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of analyst reports. Macquarie reiterated an “outperform” rating and issued a $133.00 price target on shares of Addus HomeCare in a report on Tuesday, June 10th. Barclays upped their target price on Addus HomeCare from $83.00 to $109.00 and gave the company an “underweight” rating in a research report on Tuesday. JMP Securities reaffirmed a “market outperform” rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. TD Cowen boosted their price target on Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Finally, Royal Bank Of Canada lifted their price objective on Addus HomeCare from $133.00 to $134.00 and gave the company an “outperform” rating in a research note on Friday. Two analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $138.38.

Hedge Funds Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently modified their holdings of the business. Natixis boosted its position in Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company’s stock worth $31,000 after purchasing an additional 132 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S acquired a new position in shares of Addus HomeCare during the 1st quarter worth approximately $41,000. State of Wyoming purchased a new position in shares of Addus HomeCare during the 2nd quarter valued at approximately $47,000. Raymond James Financial Inc. acquired a new stake in Addus HomeCare in the 2nd quarter valued at $61,000. Finally, CWM LLC increased its holdings in Addus HomeCare by 25.3% in the 2nd quarter. CWM LLC now owns 554 shares of the company’s stock worth $64,000 after acquiring an additional 112 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.